1.
Cellular Therapies for Muscular Dystrophies: Frustrations and Clinical Successes
by Negroni, Elisa
Human gene therapy, 2015, Vol.27 (2), p.117-126
2.
Atrophy, Fibrosis, and Increased PAX7-Positive Cells in Pharyngeal Muscles of Oculopharyngeal Muscular Dystrophy Patients
by Gidaro, Teresa
Journal of neuropathology and experimental neurology, 2013, Vol.72 (3), p.234-243
3.
Glycosaminoglycan modifications in Duchenne muscular dystrophy: specific remodeling of chondroitin sulfate/dermatan sulfate
by Negroni, E
Journal of neuropathology and experimental neurology, 2014, Vol.73 (8), p.789-797
4.
Immortalized Skin Fibroblasts Expressing Conditional MyoD as a Renewable and Reliable Source of Converted Human Muscle Cells to Assess Therapeutic Strategies for Muscular Dystrophi...
by Chaouch, Soraya
Human gene therapy, 2009, Vol.20 (7), p.784-790
5.
Nonrandom Distribution of Cryptic Repeating Triplets of Purines and Pyrimidines (RNY)n in gp120 of HIV Type1
by De Crignis, Elisa
AIDS research and human retroviruses, 2012, Vol.28 (5), p.493-504
6.
Nonrandom distribution of cryptic repeating triplets of purines and pyrimidines (RNY)(n) in gp120 of HIV Type1
by De Crignis, Elisa
AIDS research and human retroviruses, 2012, Vol.28 (5), p.493-504
7.
Non-random distribution of cryptic repeating triplets of purines and pyrimidines (RNY)n in gp120 of HIV-1
by De Crignis, Elisa
AIDS research and human retroviruses, 2011 (ja)
